Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PRDX2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC645513 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
YAE1D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIF4GD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNB1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL17RD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NECAB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM189B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00494 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRE - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HAGHL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ITIH4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC25A35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928389 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on